Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017-2021 Chapter 1 Specific Cancer Immunotherapy Drugs Market Overview 1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs 1.2 Specific Cancer Immunotherapy Drugs Market Segmentation by Type 1.2.1 Global Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015 1.2.1 Tablet 1.2.2 Injection 1.2.3 Type 3 1.3 Specific Cancer Immunotherapy Drugs Market Segmentation by Application 1.3.1 Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015 1.3.2 Leukemia Treatment 1.3.3 Colorectal Cancer Treatment 1.3.4 Other Cancer Treatment 1.4 Specific Cancer Immunotherapy Drugs Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Specific Cancer Immunotherapy Drugs (2012-2021) Chapter 2 Global Economic Impact on Specific Cancer Immunotherapy Drugs Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global Specific Cancer Immunotherapy Drugs Market Competition by Manufacturers 3.1 Global Specific Cancer Immunotherapy Drugs Production and Share by Manufacturers (2015 and 2016) 3.2 Global Specific Cancer Immunotherapy Drugs Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Specific Cancer Immunotherapy Drugs Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution, Production Area and Product Type 3.5 Specific Cancer Immunotherapy Drugs Market Competitive Situation and Trends 3.5.1 Specific Cancer Immunotherapy Drugs Market Concentration Rate 3.5.2 Specific Cancer Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Specific Cancer Immunotherapy Drugs Production, Revenue (Value) by Region (2012-2017) 4.1 Global Specific Cancer Immunotherapy Drugs Production by Region (2012-2017) 4.2 Global Specific Cancer Immunotherapy Drugs Production Market Share by Region (2012-2017) 4.3 Global Specific Cancer Immunotherapy Drugs Revenue (Value) and Market Share by Region (2012-2017) 4.4 Global Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.5 North America Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.6 Europe Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.7 China Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.8 Japan Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.9 Southeast Asia Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.10 India Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Chapter 5 Global Specific Cancer Immunotherapy Drugs Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5.1 Global Specific Cancer Immunotherapy Drugs Consumption by Regions (2012-2017) 5.2 North America Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.3 Europe Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.4 China Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.5 Japan Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.6 Southeast Asia Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.7 India Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017) Chapter 6 Global Specific Cancer Immunotherapy Drugs Production, Revenue (Value), Price Trend by Type 6.1 Global Specific Cancer Immunotherapy Drugs Production and Market Share by Type (2012-2017) 6.2 Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2012-2017) 6.3 Global Specific Cancer Immunotherapy Drugs Price by Type (2012-2017) 6.4 Global Specific Cancer Immunotherapy Drugs Production Growth by Type (2012-2017) Chapter 7 Global Specific Cancer Immunotherapy Drugs Market Analysis by Application 7.1 Global Specific Cancer Immunotherapy Drugs Consumption and Market Share by Application (2012-2017) 7.2 Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Specific Cancer Immunotherapy Drugs Manufacturers Analysis 8.1 Amgen 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.1.4 Business Overview 8.2 Roche 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.2.4 Business Overview 8.3 Bristol Myers Squibb 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.3.4 Business Overview 8.4 Dendreon (Valeant) 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.4.4 Business Overview 8.5 Novartis 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.5.4 Business Overview 8.6 Seattle Genetics 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.6.4 Business Overview 8.7 Hangzhou Jinjiang Group 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.7.4 Business Overview 8.8 company 8 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.8.4 Business Overview 8.9 company 9 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.9.4 Business Overview … Chapter 9 Specific Cancer Immunotherapy Drugs Manufacturing Cost Analysis 9.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global Specific Cancer Immunotherapy Drugs Market Forecast (2017-2021) 13.1 Global Specific Cancer Immunotherapy Drugs Production, Revenue Forecast (2017-2021) 13.2 Global Specific Cancer Immunotherapy Drugs Production, Consumption Forecast by Regions (2017-2021) 13.3 Global Specific Cancer Immunotherapy Drugs Production Forecast by Type (2017-2021) 13.4 Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2017-2021) 13.5 Specific Cancer Immunotherapy Drugs Price Forecast (2017-2021) Chapter 14 Appendix

Figure Picture of Specific Cancer Immunotherapy Drugs Figure Global Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015 Figure Leukemia Treatment Examples Figure Colorectal Cancer Treatment Examples Figure Other Cancer Treatment Examples Figure North America Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Global Specific Cancer Immunotherapy Drugs Revenue (Million UDS) and Growth Rate (2012-2021) Table Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers (2015 and 2016) Table Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Manufacturers (2015 and 2016) Figure Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2015 Figure Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2016 Table Global Specific Cancer Immunotherapy Drugs Production of Key Manufacturers (2015 and 2016) Table Global Specific Cancer Immunotherapy Drugs Production Share by Manufacturers (2015 and 2016) Figure 2015 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers Figure 2016 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers Table Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers Table 2016 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers Table Global Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016) Figure Global Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers in 2015 Table Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Specific Cancer Immunotherapy Drugs Product Type Figure Specific Cancer Immunotherapy Drugs Market Share of Top 3 Manufacturers Figure Specific Cancer Immunotherapy Drugs Market Share of Top 5 Manufacturers Table Global Specific Cancer Immunotherapy Drugs Capacity by Regions (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions (2012-2017) Figure 2015 Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions Table Global Specific Cancer Immunotherapy Drugs Production by Regions (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Production and Market Share by Regions (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Production Market Share by Regions (2012-2017) Figure 2015 Global Specific Cancer Immunotherapy Drugs Production Market Share by Regions Table Global Specific Cancer Immunotherapy Drugs Revenue by Regions (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Revenue Market Share by Regions (2012-2017) Table 2015 Global Specific Cancer Immunotherapy Drugs Revenue Market Share by Regions Table Global Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table North America Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Europe Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table China Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Japan Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Southeast Asia Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table India Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Consumption Market by Regions (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions (2012-2017) Figure 2015 Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions Table North America Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table Europe Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table China Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table Japan Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table Southeast Asia Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table India Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Production by Type (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Production Share by Type (2012-2017) Figure Production Market Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017) Figure 2015 Production Market Share of Specific Cancer Immunotherapy Drugs by Type Table Global Specific Cancer Immunotherapy Drugs Revenue by Type (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Type (2012-2017) Figure Production Revenue Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017) Figure 2015 Revenue Market Share of Specific Cancer Immunotherapy Drugs by Type Table Global Specific Cancer Immunotherapy Drugs Price by Type (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Production Growth by Type (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Consumption by Application (2012-2017) Table Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Application (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015 Table Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017) Figure Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017) Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors Table Amgen Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Amgen Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors Table Roche Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Roche Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Bristol Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Dendreon (Valeant) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novartis Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Novartis Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Seattle Genetics Basic Information, Manufacturing Base, Production Area and Its Competitors Table Seattle Genetics Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Seattle Genetics Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table Hangzhou Jinjiang Group Basic Information, Manufacturing Base, Production Area and Its Competitors Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors Table company 8 Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table company 8 Specific Cancer Immunotherapy Drugs Market Share (2012-2017) Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors Table company 9 Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table company 9 Specific Cancer Immunotherapy Drugs Market Share (2012-2017) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015 Table Major Buyers of Specific Cancer Immunotherapy Drugs Table Distributors/Traders List Figure Global Specific Cancer Immunotherapy Drugs Production and Growth Rate Forecast (2017-2021) Figure Global Specific Cancer Immunotherapy Drugs Revenue and Growth Rate Forecast (2017-2021) Table Global Specific Cancer Immunotherapy Drugs Production Forecast by Regions (2017-2021) Table Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Regions (2017-2021) Table Global Specific Cancer Immunotherapy Drugs Production Forecast by Type (2017-2021) Table Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2017-2021)

Amgen Roche Bristol Myers Squibb Dendreon (Valeant) Novartis Seattle Genetics Hangzhou Jinjiang Group